NexPoint Real Estate Opportunities LLC 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-27 08:20 am Unchanged | 2023-06-27 | 13D | Paratek Pharmaceuticals, Inc. PRTK | NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% | 0 (Unchanged) | Filing |
| 2023-03-30 4:30 pm Purchase | 2023-03-16 | 13D | Paratek Pharmaceuticals, Inc. PRTK | NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% | 2,822,250 (+72.92%) | Filing |
| 2023-03-24 6:40 pm Purchase | 2023-03-16 | 13D | Paratek Pharmaceuticals, Inc. PRTK | NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% | 6,692,447 (New Position) | Filing |
| 2023-01-20 4:15 pm Purchase | 2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK | NexPoint Real Estate Opportunities LLC | 3,870,197 6.970% | 3,870,197 (New Position) | Filing |